This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Mar 12;296(6624):731-2.

doi: 10.1136/bmj.296.6624.731.

Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?

R J Northcote¹

Affiliations

PMID: 2894885
PMCID: PMC2545359
DOI: 10.1136/bmj.296.6624.731

Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?

R J Northcote. Br Med J (Clin Res Ed). 1988.

. 1988 Mar 12;296(6624):731-2.

doi: 10.1136/bmj.296.6624.731.

Author

R J Northcote¹

Affiliation

¹ Royal Infirmary, Glasgow.

PMID: 2894885
PMCID: PMC2545359
DOI: 10.1136/bmj.296.6624.731

No abstract available

PubMed Disclaimer

Similar articles

[The metabolic side effects of beta-receptor blockers].
Schauer UJ. Schauer UJ. Dtsch Med Wochenschr. 1992 Oct 16;117(42):1617-8. Dtsch Med Wochenschr. 1992. PMID: 1356748 German. No abstract available.
Recent studies on the effects of beta blockers on blood lipid levels.
Roberts WC. Roberts WC. Am Heart J. 1989 Mar;117(3):709-14. doi: 10.1016/0002-8703(89)90757-6. Am Heart J. 1989. PMID: 2563923 Review. No abstract available.
[Lipoprotein metabolism and beta receptor blockers].
Schauer UJ, Schauer I. Schauer UJ, et al. Z Gesamte Inn Med. 1987 Apr 15;42(8):201-5. Z Gesamte Inn Med. 1987. PMID: 2888241 German.
[Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
Rouffy J, Chanu B, Bakir R, Sauvanet JP. Rouffy J, et al. J Pharmacol. 1983;14 Suppl 2:183-99. J Pharmacol. 1983. PMID: 6138467 Review. French.
[Beta-adrenergic inhibitors and atherogenic risk].
Jacotot B, Richard JL. Jacotot B, et al. Therapie. 1985 Nov-Dec;40(6):387-91. Therapie. 1985. PMID: 2868532 French. No abstract available.

See all similar articles

Cited by

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?
Waller DG. Waller DG. Br J Clin Pharmacol. 1990 Aug;30(2):157-71. doi: 10.1111/j.1365-2125.1990.tb03760.x. Br J Clin Pharmacol. 1990. PMID: 1976342 Free PMC article. Review. No abstract available.
The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.
Bain SC, Dodson PM. Bain SC, et al. Postgrad Med J. 1991 Oct;67(792):922-7. doi: 10.1136/pgmj.67.792.922. Postgrad Med J. 1991. PMID: 1758805 Free PMC article. Review. No abstract available.
Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension.
Terént A, Ribacke M, Carlson LA. Terént A, et al. Eur J Clin Pharmacol. 1989;36(4):347-50. doi: 10.1007/BF00558293. Eur J Clin Pharmacol. 1989. PMID: 2737226

References

1. Atherosclerosis. 1973 Sep-Oct;18(2):337-45 - PubMed
1. J Hypertens. 1987 Aug;5(4):489-98 - PubMed
1. Circulation. 1977 May;55(5):767-72 - PubMed
1. Lancet. 1977 May 7;1(8019):965-8 - PubMed
1. Am J Med. 1977 May;62(5):707-14 - PubMed

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information